Updated July 2026 · 7 min read

Local Anesthetic Systemic Toxicity (LAST) for ICU Nurses 2026 — The Lipid Rescue

Part of the ICU Emergencies Hub — browse every related guide in one place.

Local anesthetics are everywhere in the hospital — nerve blocks, epidurals, line placement, laceration repair, the numbing before a chest tube. They're safe in the right dose in the right place, but push too much into the bloodstream and they become cardiac and neurologic poisons. Local anesthetic systemic toxicity (LAST) is the emergency that follows, and it has one of the most distinctive antidotes in medicine: a bag of fat. For a nurse eyeing CRNA school, understanding LAST is essential, because regional anesthesia is core to the job and this is its signature complication.

How the drug gets where it shouldn't

Local anesthetics work by blocking sodium channels in nerves. Kept in the tissue where they're injected, they numb an area and wear off. Trouble starts when a large amount reaches the systemic circulation, either because the needle was inadvertently in a vessel during a block, or because a big dose in a vascular area was absorbed faster than the body could clear it. Once blood levels climb, those same sodium-channel effects hit the brain and heart. The more potent, longer-acting agents (like bupivacaine) are especially cardiotoxic and harder to resuscitate, which is why total dose limits and careful technique matter so much. LAST can appear within a minute of an intravascular injection or be delayed many minutes as absorption peaks — so the monitoring window after a block isn't over when the injection is done.

The progression — brain first, then heart (usually)

Classically the nervous system shows the first warnings. Patients describe circumoral (around-the-mouth) numbness or tingling, a metallic taste, ringing in the ears, lightheadedness, or visual changes, and may become agitated or confused. This can escalate to seizures. As levels rise further, the heart is affected: widening QRS and conduction blocks, bradycardia or tachyarrhythmias, profound hypotension, and ultimately cardiac arrest that is notoriously resistant to standard resuscitation. Importantly, the neat “neuro-then-cardiac” sequence isn't guaranteed — with the potent agents, cardiovascular collapse can be the presenting event with little warning, so any hemodynamic catastrophe around a local-anesthetic procedure should raise LAST.

Lipid rescue — the antidote in the drawer

The treatment that makes LAST different is intravenous lipid emulsion. The prevailing idea is that the infused lipid acts as a “sink,” pulling the fat-soluble anesthetic out of the heart tissue and buffering it in the bloodstream, while also supporting cardiac energy metabolism. Given as a bolus and then an infusion at the first sign of serious toxicity, it can restore a failing circulation that wasn't responding to conventional measures. Every area that performs regional anesthesia is expected to keep lipid emulsion and a LAST checklist immediately available, and the nurse should know where that kit lives before it's needed — in a real event, minutes matter and hunting for the bag is time the heart doesn't have.

Supportive care and the ACLS twist

Around the lipid, the fundamentals still apply and come first: stop giving the drug, get help, protect the airway and oxygenate (hypoxia and acidosis make cardiotoxicity worse), and control seizures with benzodiazepines. If the patient arrests, resuscitation follows a LAST-modified approach — prolonged effort is warranted because these patients can recover after long resuscitations once the lipid takes effect, and the doses of some standard ACLS drugs are adjusted. Because the definitive fix for the drug's cardiac effect may be lipid plus time, in refractory cases mechanical circulatory support (like ECMO) is considered as a bridge. The nurse manages the airway, the drips, the lipid infusion, and the rhythm through what can be a long event.

The nursing bottom line

LAST is what happens when local anesthetic reaches toxic levels in the blood, usually from intravascular injection or an oversized dose, and it poisons the brain and heart. The classic march is neurologic warnings — perioral numbness, metallic taste, tinnitus, agitation, seizures — followed by cardiac toxicity and possible arrest, though the potent agents can go straight to collapse. The distinctive antidote is intravenous lipid emulsion, given alongside airway support, seizure control, and a LAST-modified ACLS, with prolonged resuscitation justified. Prevention through dose limits and careful technique is the real win, and the bedside nurse — especially the future CRNA — is the one who catches the early neurologic clues after a block and knows exactly where the lipid rescue kit is kept.

Related: What is a CRNA · Methemoglobinemia · Status epilepticus · Vasopressors

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.